Oric Pharmaceuticals, Inc. (ORIC) Financials

ORIC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 254.7 million 30.6 million
2023-09-30 274.3 million 26.9 million
2023-06-30 291.8 million 23.0 million
2023-03-31 226.6 million 23.8 million

ORIC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -24.6 million 3.9 million
2023-09-30 -19.7 million 3.9 million
2023-06-30 -21.6 million 3.8 million
2023-03-31 -20.9 million 3.6 million

ORIC Net Income

No data available :(

ORIC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 208.2 million - 2.8 million
2023-09-30 227.3 million - 2.7 million
2023-06-30 264.2 million - 2.7 million
2023-03-31 189.6 million - 2.7 million

ORIC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 57.5 million
2023-09-30 57.4 million
2023-06-30 45.7 million
2023-03-31 45.1 million

ORIC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 57000 24.5 million 6.9 million 263000
2023-09-30 77000 22.4 million 6.3 million -
2023-06-30 405000 18.8 million 6.2 million -
2023-03-31 310000 19.5 million 6.2 million -

ORIC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 263000
2023-09-30 - 257000
2023-06-30 - 259000
2023-03-31 - 253000

ORIC

Price: $9.54

52 week price:
4.89
16.65

Earnings Per Share: -1.96 USD

P/E Ratio: -6.39

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 145300

Market Capitalization: 753.9 million

Links: